FDA approves Jardiance (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction Read more
Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program Read more
Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America Read more
AbbVie Submits Supplemental New Drug Application to U.S. FDA for cariprazine (VRAYLAR®) for the Adjunctive Treatment of Major Depressive Disorder Read more